AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

$237 Million Molecular Quality Controls Market by Product, Analyte Type, Application and End-user - Global Forecast to 2024 - ResearchAndMarkets.com

February 14, 2019

DUBLIN--(BUSINESS WIRE)--Feb 14, 2019--The “Molecular Quality Controls Market by Product (Independent, Instrument Specific), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.

The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period.

The molecular quality controls market is driven primarily by the rising adoption of third-party quality controls, an increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support.

However, the high costs involved in the quality control process, budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are expected to restrain the growth of this market during the forecast period.

The infectious diseases segment held the largest share of the molecular controls market in 2018

Based on application, the molecular controls market is divided into four major segments - infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment accounted for the largest share of the molecular controls market in 2018.

The large share of this segment is attributed to the development of advanced assays for different infectious diseases, a significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of MDx technologies or products to control the occurrence and spread of infectious diseases.

Asia Pacific projected to grow at the highest CAGR during the forecast period.

The Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular controls market.

Market Dynamics

Drivers

  • Increasing Number of Accredited Clinical Laboratories
  • Growing Adoption of Third-Party Quality Controls
  • Rising Demand for External Quality Assessment Support

Restraints

  • Additional Costs Involved in Quality Control and Budget Constraints in Hospitals & Laboratories
  • Unfavorable Reimbursement Scenario for Molecular Tests

Opportunities

  • Rising Demand for Multi-Analyte Controls

Challenges

  • Lack of Mandatory Regulations for Clinical Laboratory Accreditation in Several Emerging Countries
  • Complex Regulatory Frameworks

Topics Covered

1 Introduction

1.1 Objectives of the Study

1.2 Market Definition

1.3 Market Scope

1.4 Currency

1.5 Limitations

1.6 Stakeholders

2 Research Methodology

2.1 Research Data

2.2 Market Size Estimation

2.3 Market Breakdown and Data Triangulation

3 Executive Summary

3.1 Introduction

4 Premium Insights

4.1 Molecular Quality Controls: Market Overview

4.2 Molecular Quality Controls Market, By Product

4.3 North America: Molecular Quality Controls Market, By End User (2018)

5 Market Overview

5.1 Introduction

6 Molecular Quality Controls Market, By Product

6.1 Introduction

6.2 Independent Controls

6.3 Instrument-Specific Controls

7 Molecular Quality Controls Market, By Analyte Type

7.1 Introduction

7.2 Single-Analyte Controls

7.3 Multi-Analyte Controls

8 Molecular Quality Controls Market, By Application

8.1 Introduction

8.2 Infectious Diseases

8.3 Oncology

8.4 Genetic Testing

8.5 Other Applications

9 Molecular Quality Controls Market, By End User

9.1 Introduction

9.2 Clinical Laboratories

9.3 Hospitals

9.4 IVD Manufacturers and Contract Research Organizations

9.5 Academic & Research Institutes

9.6 Other End Users

10 Molecular Quality Controls Market, By Region

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia Pacific

10.5 Rest of the World

11 Competitive Landscape

11.1 Market Overview

11.2 Market Ranking Analysis, 2017

11.3 Competitive Benchmarking

12 Company Profiles

12.1 Seracare Life Sciences Inc.

12.2 Thermo Fisher Scientific

12.3 Bio-Rad Laboratories

12.4 Microbiologics Inc.

12.5 Zeptometrix

12.6 Roche Diagnostics

12.7 Abbott Laboratories

12.8 Quidel

12.9 Qnostics

12.10 Maine Molecular Quality Controls Inc.

For more information about this report visit https://www.researchandmarkets.com/research/8d499k/237_million?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190214005828/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: RESEARCH SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/14/2019 02:28 PM/DISC: 02/14/2019 02:28 PM

http://www.businesswire.com/news/home/20190214005828/en